DE69635224D1 - 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität - Google Patents

1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität

Info

Publication number
DE69635224D1
DE69635224D1 DE69635224T DE69635224T DE69635224D1 DE 69635224 D1 DE69635224 D1 DE 69635224D1 DE 69635224 T DE69635224 T DE 69635224T DE 69635224 T DE69635224 T DE 69635224T DE 69635224 D1 DE69635224 D1 DE 69635224D1
Authority
DE
Germany
Prior art keywords
pdeiv
cytokin
dihydro
imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635224T
Other languages
English (en)
Other versions
DE69635224T2 (de
Inventor
Jean Freyne
Stanislas Diels
Ignacio Andres-Gil
Javier Fernandez-Gadea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE69635224D1 publication Critical patent/DE69635224D1/de
Publication of DE69635224T2 publication Critical patent/DE69635224T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
DE69635224T 1995-04-06 1996-03-28 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität Expired - Lifetime DE69635224T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200870 1995-04-06
EP95200870 1995-04-06
PCT/EP1996/001393 WO1996031487A1 (en) 1995-04-06 1996-03-28 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity

Publications (2)

Publication Number Publication Date
DE69635224D1 true DE69635224D1 (de) 2006-02-09
DE69635224T2 DE69635224T2 (de) 2006-06-22

Family

ID=8220175

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635224T Expired - Lifetime DE69635224T2 (de) 1995-04-06 1996-03-28 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität

Country Status (15)

Country Link
US (1) US5869515A (de)
EP (1) EP0832071B1 (de)
JP (1) JP4115519B2 (de)
KR (1) KR100400159B1 (de)
CN (1) CN1103760C (de)
AR (1) AR002984A1 (de)
AT (1) ATE305455T1 (de)
CA (1) CA2216542C (de)
DE (1) DE69635224T2 (de)
ES (1) ES2250988T3 (de)
IL (1) IL117806A (de)
MY (1) MY117936A (de)
TW (1) TW375612B (de)
WO (1) WO1996031487A1 (de)
ZA (1) ZA962753B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
PL194673B1 (pl) * 1996-10-02 2007-06-29 Janssen Pharmaceutica Nv Pochodna 2-cyjanoiminoimidazolu, sposób jej wytwarzania i zastosowanie oraz kompozycja farmaceutyczna
DE69912590T2 (de) * 1998-04-01 2004-09-16 Janssen Pharmaceutica N.V. Pde-iv-hemmende pyridin-derivate
JP5038568B2 (ja) 1999-08-21 2012-10-03 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 協力剤の組合せ物
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
FR2860514A1 (fr) * 2003-10-03 2005-04-08 Sanofi Synthelabo Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
GEP20084550B (en) 2004-04-30 2008-11-25 Warner Lambert Co Substituted morpholine compounds for the treatment of central nervous system disorders
WO2006078698A1 (en) * 2005-01-19 2006-07-27 Cengent Therapeutics, Inc. 2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases
JP2009525269A (ja) * 2006-01-30 2009-07-09 ユーロ−セルティーク エス．エイ． カルシウムチャネルブロッカーとしての環状尿素化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
CA1309096C (en) * 1985-08-13 1992-10-20 Sumitomo Chemical Co., Ltd. Butenoic acid derivatives, and their production and use
US4845233A (en) * 1987-09-11 1989-07-04 Iprx, Inc. Imidazolin-2-ones
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
CA2140441C (en) * 1992-07-28 2006-11-21 Garry Fenton Inhibitors of c-amp phosphodiesterase and tnf
CA2160928C (en) * 1993-07-28 2005-07-05 Garry Fenton Compounds as pde iv and tnf inhibitors
GB9401460D0 (en) * 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
DE69526790T2 (de) * 1994-06-24 2003-03-06 Euro Celtique Sa Verbindungen zur hemmung von phosphodiesrerase iv

Also Published As

Publication number Publication date
IL117806A (en) 2000-02-17
AR002984A1 (es) 1998-05-27
MY117936A (en) 2004-08-30
KR100400159B1 (ko) 2003-12-31
CA2216542A1 (en) 1996-10-10
EP0832071A1 (de) 1998-04-01
KR19980703448A (ko) 1998-11-05
WO1996031487A1 (en) 1996-10-10
IL117806A0 (en) 1996-08-04
JP4115519B2 (ja) 2008-07-09
CN1181073A (zh) 1998-05-06
DE69635224T2 (de) 2006-06-22
TW375612B (en) 1999-12-01
ZA962753B (en) 1997-10-06
ATE305455T1 (de) 2005-10-15
AU697390B2 (en) 1998-10-01
AU5497996A (en) 1996-10-23
ES2250988T3 (es) 2006-04-16
CA2216542C (en) 2009-01-13
EP0832071B1 (de) 2005-09-28
JPH11504003A (ja) 1999-04-06
CN1103760C (zh) 2003-03-26
US5869515A (en) 1999-02-09

Similar Documents

Publication Publication Date Title
CY2005010I2 (el) Ο-αλκυλιωμενα παραγωγα ραπαμυκινης και η χρηση τους, ιδιαιτερως ως ανοσοκατασταλτικων
DE69619661T2 (de) 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-on-derivate mit pde iv-und cytokin-inhibisender aktivität
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
NL350016I1 (nl) 3-Aryl-4-hydroxy-delta#3-dihydrofuranon-en 3-aryl-4-hydroxy-delta#3-dihydrothiofenon-derivaten.
EE9700190A (et) Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena
HUP0000369A3 (en) 3-thiocarbamoylpyrazole derivatives and their use as pesticides
DE59711118D1 (de) Spickeln, Zunehmen und Mindern
DE69831233D1 (de) Barbitursaure derivaten mit antimetastatischer und antitumorischer wirkung
ZA976222B (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
DE69832184D1 (de) O-substituierte hydroxycumaranonderivate mit antitumoraler und antimetastatischer wirkung
DK0721457T3 (da) 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet
DE69424051T2 (de) Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität
DK1140835T3 (da) 3,3-biarylpiperidin- og 2,2-biarylmorpholon-derivater
MX9203459A (es) Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
DE69637363D1 (de) 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on-derivate mit pde iv und cytokin-inhibirendes aktivität
DE69635224D1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
EE03614B1 (et) Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.
DE69712425D1 (de) Naphthalin-Derivate, Zwischenprodukte und Verwendungen
DE68919507D1 (de) 2-Pyridylmethylthio-Derivate und antiulzerierendes Mittel.
ITBS950006A0 (it) Passaverdure perfezionato
BR9508669A (pt) Novos derivados de taizoloÚ3,2-a¾quinolina e naftirina
TR24169A (tr) Benzohidroksamik tuerevleri, bunlarin herbisitler olarak kullanilmasi vebunlari

Legal Events

Date Code Title Description
8364 No opposition during term of opposition